Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Clinical trial NCT07751042 · RECRUITING
Trial details
- NCT number
- NCT07751042
- Sponsor
- Strand Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2030-07-17
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.